These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9788437

  • 1. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells.
    Wang Q, Zhang H, Kajino K, Greene MI.
    Oncogene; 1998 Oct 15; 17(15):1939-48. PubMed ID: 9788437
    [Abstract] [Full Text] [Related]

  • 2. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
    Rao G, Alland L, Guida P, Schreiber-Agus N, Chen K, Chin L, Rochelle JM, Seldin MF, Skoultchi AI, DePinho RA.
    Oncogene; 1996 Mar 07; 12(5):1165-72. PubMed ID: 8649810
    [Abstract] [Full Text] [Related]

  • 3. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ, Ayer DE, Eisenman RN.
    Cell Growth Differ; 1995 Jun 07; 6(6):623-9. PubMed ID: 7669717
    [Abstract] [Full Text] [Related]

  • 4. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

  • 5. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
    Huang A, Ho CS, Ponzielli R, Barsyte-Lovejoy D, Bouffet E, Picard D, Hawkins CE, Penn LZ.
    Cancer Res; 2005 Jul 01; 65(13):5607-19. PubMed ID: 15994933
    [Abstract] [Full Text] [Related]

  • 6. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X, Giap C, Lazo JS, Prochownik EV.
    Oncogene; 2003 Sep 18; 22(40):6151-9. PubMed ID: 13679853
    [Abstract] [Full Text] [Related]

  • 7. Cdc25 cell-cycle phosphatase as a target of c-myc.
    Galaktionov K, Chen X, Beach D.
    Nature; 1996 Aug 08; 382(6591):511-7. PubMed ID: 8700224
    [Abstract] [Full Text] [Related]

  • 8. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
    Min S, Mascarenhas NT, Taparowsky EJ.
    Oncogene; 1993 Oct 08; 8(10):2691-701. PubMed ID: 8378081
    [Abstract] [Full Text] [Related]

  • 9. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP, Fernández-García B, García-Sanz P, Ferrandiz N, Bretones G, Calvo F, Crespo P, Marín MC, León J.
    Mol Cancer Res; 2008 Feb 08; 6(2):325-39. PubMed ID: 18314492
    [Abstract] [Full Text] [Related]

  • 10. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

  • 11. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J, Lüscher B.
    Biol Chem; 1999 Sep 01; 380(9):1121-6. PubMed ID: 10543451
    [Abstract] [Full Text] [Related]

  • 12. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC.
    Oncogene; 1999 Jun 17; 18(24):3564-73. PubMed ID: 10380878
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z, Ge L, Wang M, Carr BI.
    J Cell Physiol; 2006 Jul 17; 208(1):133-40. PubMed ID: 16596619
    [Abstract] [Full Text] [Related]

  • 14. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
    D'Agnano I, Valentini A, Gatti G, Chersi A, Felsani A.
    J Cell Physiol; 2007 Jan 17; 210(1):72-80. PubMed ID: 16998799
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep 17; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 16. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
    Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN.
    Oncogene; 2001 Mar 15; 20(11):1357-67. PubMed ID: 11313879
    [Abstract] [Full Text] [Related]

  • 17. Functions of myc:max in the control of cell proliferation and tumorigenesis.
    Hurlin PJ, Dezfouli S.
    Int Rev Cytol; 2004 Mar 15; 238():183-226. PubMed ID: 15364199
    [Abstract] [Full Text] [Related]

  • 18. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY, Li CY, Li Y, Zhan YQ, Li YH, Xu CW, Xu WX, Sun HB, Yang XM.
    Cell Death Differ; 2009 Mar 15; 16(3):395-405. PubMed ID: 19008924
    [Abstract] [Full Text] [Related]

  • 19. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
    Popov N, Wahlström T, Hurlin PJ, Henriksson M.
    Oncogene; 2005 Dec 15; 24(56):8326-37. PubMed ID: 16103876
    [Abstract] [Full Text] [Related]

  • 20. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE.
    Oncogene; 2001 Mar 29; 20(14):1688-702. PubMed ID: 11313917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.